Human IL-5 R alpha/CD125 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF-253-NA
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Endotoxin Level
Scientific Data Images for Human IL-5 R alpha/CD125 Antibody
Neutralization by Human IL-5 R alpha/CD125 Antibody.
Human IL-5 R alpha/CD125 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-253-NA) neutralizes IL 5-induced proliferation in the TF-1 human erythroleukemic cell line. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The Neutralization Dose (ND50) is typically 0.0800-0.800 µg/mL in the presence of 0.5 ng/mL Recombinant Human IL-5 (205-IL).Detection of IL-5 R alpha/CD125 in HEK293 human embryonic kidney cell line transfected with human IL-5 receptor alpha vs. HEK293 human embryonic kidney cell line transfected with an irrelevant protein by Flow Cytometry.
HEK293 human embryonic kidney cell line transfected with human IL-5 receptor alpha (filled histogram) vs HEK293 human embryonic kidney cell line transfected with an irrelevant protein (open histogram) were stained with Goat Anti-Human IL-5 R alpha/CD125 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-253-NA) followed by Allophycocyanin-conjugated Anti-Goat IgG Secondary Antibody (F0108). View our protocol for Staining Membrane-associated Proteins.Applications for Human IL-5 R alpha/CD125 Antibody
CyTOF-ready
Flow Cytometry
Sample: HEK293 human embryonic kidney cell line transfected with human IL-5 receptor alpha vs HEK293 human embryonic kidney cell line transfected with an irrelevant protein.
Western Blot
Sample: Recombinant Human IL-5 R alpha/CD125 (Catalog # 253-5R)
Neutralization
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
*Small pack size (-SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-5 R alpha/CD125
Interleukin 5, produced primarily by activated T cells and mast cells, has diverse biological effects on a variety of cell types. Human IL-5 is a potent eosinophil differentiation and activation factor in vivo and in vitro. Additionally, it has also been reported that IL-5 can stimulate the proliferation and/or differentiation of basophils and B cells. The multiple effects of IL-5 are mediated by binding of the cytokine to specific cell surface receptors expressed on target cells. As is the case with many other cytokines, the functional high-affinity receptor for IL-5 is a complex consisting of a ligand binding subunit ( alpha chain) and a second subunit ( beta chain) that can modulate the ligand binding affinity of the receptor complex. In the case of IL-5, the beta subunit is shared with the high affinity receptor complexes for IL-3 and GM-CSF. The beta chain does not bind any of the cytokines in question but is indispensable for the cytokine-mediated signaling.
cDNA clones for the alpha chain (IL-5 R alpha) of both the mouse and human high affinity IL-5 receptor complexes have been isolated. Human and mouse IL-5 R alpha are both members of the hematopoietin receptor superfamily characterized by the presence of the WSXWS, and a four cysteine residue motif in the extracellular domain of the transmembrane protein. In addition to the cDNA clone encoding the full-length transmembrane protein, cDNA clones that arise from alternative splicing and that encode soluble secreted forms of IL-5 R alpha have been isolated from mouse as well as human cells. A naturally-occurring soluble form of the IL-5 R alpha has been detected in biological fluids of autoimmune-prone mice and mice bearing chronic B cell leukemia (BCL1).
A recombinant human IL-5 soluble receptor alpha has been shown to bind the human IL-5 dimer in a 1:1 ratio and acts as a human IL-5 antagonist. This molecule inhibits the proliferation of IL-5-dependent cell lines and blocks human umbilical cord blood eosinophil differentiation.
Long Name
Alternate Names
Gene Symbol
Additional IL-5 R alpha/CD125 Products
Product Documents for Human IL-5 R alpha/CD125 Antibody
Product Specific Notices for Human IL-5 R alpha/CD125 Antibody
For research use only